$DATS
DatChat, Inc. Stock $dats

$dats Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121390023066984 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$175.00	$172.00	$37.95K
YoY Change	-95.06%	-99.55%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.162M	$1.989M	$2.534M
YoY Change	-10.63%	-21.47%	292.23%
% of Gross Profit
Research & Development	$380.0K	$337.5K
YoY Change	46.75%
% of Gross Profit
Depreciation & Amortization	$10.69K	$7.160K	$4.230K
YoY Change	-82.02%	69.27%
% of Gross Profit
Operating Expenses	$2.542M	$337.5K	$2.534M
YoY Change	881.76%	-86.68%	292.23%
Operating Profit	-$2.542M	-$2.327M	-$2.580M
YoY Change	-5.21%	-9.81%	299.39%
Interest Expense	$177.6K	$39.53K
YoY Change
% of Operating Profit
Other Income/Expense, Net	$177.6K	$39.53K	-$1.946K
YoY Change	604.51%	-2131.29%	-1414.86%
Pretax Income	-$2.365M	-$2.287M	-$2.582M
YoY Change	-11.0%	-11.41%	299.78%
Income Tax
% Of Pretax Income
Net Earnings	-$2.365M	-$2.287M	-$2.582M
YoY Change	-11.0%	-11.41%	299.78%
Net Earnings / Revenue	-1351188.57%	-1329784.88%	-6803.47%
Basic Earnings Per Share	-$1.13	-$0.11	-$0.13
Diluted Earnings Per Share	-$1.13	-$0.11	-$0.13
COMMON SHARES
Basic Shares Outstanding	20.94M shares	20.74M shares	19.61M shares
Diluted Shares Outstanding	2.089M shares	20.74M shares	19.61M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.499M	$9.407M	$16.24M
YoY Change	-47.23%	-42.09%	1373.47%
Cash & Equivalents	$672.1K	$1.068M	$8.597M
Short-Term Investments	$6.827M	$8.339M	$7.646M
Other Short-Term Assets	$277.9K	$117.2K	$53.37K
YoY Change	7.07%	119.52%	-70.19%
Inventory
Prepaid Expenses	$277.9K
Receivables	$142.00	$107.00	$243.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$7.777M	$9.524M	$16.30M
YoY Change	-46.26%	-41.56%	1171.8%
LONG-TERM ASSETS
Property, Plant & Equipment	$108.5K	$98.94K	$71.55K
YoY Change	26.94%	38.28%	378.26%
Goodwill
YoY Change
Intangibles			$1.090M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$0.00	$59.13K
YoY Change	-100.0%	-100.0%
Total Long-Term Assets	$198.7K	$204.7K	$1.381M
YoY Change	-84.95%	-85.18%	9139.36%
TOTAL ASSETS
Total Short-Term Assets	$7.777M	$9.524M	$16.30M
Total Long-Term Assets	$198.7K	$204.7K	$1.381M
Total Assets	$7.976M	$9.728M	$17.68M
YoY Change	-49.49%	-44.97%	1263.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$390.3K	$428.3K	$432.1K
YoY Change	2.41%	-0.87%	145.45%
Accrued Expenses	$79.35K	$75.17K	$60.27K
YoY Change	24.61%	24.72%	302.87%
Deferred Revenue	$78.00	$105.00	$7.311K
YoY Change	-97.98%	-98.56%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$469.7K	$503.6K	$499.7K
YoY Change	4.69%	0.78%	151.97%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$22.85K	$44.04K	$119.2K
YoY Change	-77.64%	-63.06%
Total Long-Term Liabilities	$22.85K	$44.04K	$119.2K
YoY Change	-77.64%	-63.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$469.7K	$503.6K	$499.7K
Total Long-Term Liabilities	$22.85K	$44.04K	$119.2K
Total Liabilities	$492.6K	$547.6K	$618.9K
YoY Change	-10.58%	-11.51%	212.08%
SHAREHOLDERS EQUITY
Retained Earnings	-$46.78M	-$44.42M	-$33.54M
YoY Change	29.25%	32.43%
Common Stock	$209.00	$2.074K	$2.060K
YoY Change	-89.85%	0.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$398.0K	$398.0K
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.483M	$9.181M	$17.06M
YoY Change
Total Liabilities & Shareholders Equity	$7.976M	$9.728M	$17.68M
YoY Change	-49.49%	-44.97%	1263.69%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$2.365M	-$2.287M	-$2.582M
YoY Change	-11.0%	-11.41%	299.78%
Depreciation, Depletion And Amortization	$10.69K	$7.160K	$4.230K
YoY Change	-82.02%	69.27%
Cash From Operating Activities	-$1.980M	-$1.421M	-$1.463M
YoY Change	-2.65%	-2.92%	181.6%
INVESTING ACTIVITIES
Capital Expenditures	$19.49K	$32.19K	-$32.49K
YoY Change	-203.23%	-199.08%
Acquisitions
YoY Change
Other Investing Activities	$1.596M	$1.850M	-$7.650M
YoY Change	-607.08%	-124.18%
Cash From Investing Activities	$1.587M	$1.818M	-$7.682M
YoY Change	-575.54%	-123.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.720K	-86.79K	0.000
YoY Change			-100.0%
NET CHANGE
Cash From Operating Activities	-1.980M	-1.421M	-1.463M
Cash From Investing Activities	1.587M	1.818M	-7.682M
Cash From Financing Activities	1.720K	-86.79K	0.000
Net Change In Cash	-390.9K	310.5K	-9.145M
YoY Change	-83.49%	-103.39%	1639.49%
FREE CASH FLOW
Cash From Operating Activities	-$1.980M	-$1.421M	-$1.463M
Capital Expenditures	$19.49K	$32.19K	-$32.49K
Free Cash Flow	-$1.999M	-$1.453M	-$1.431M
YoY Change	-0.77%	1.53%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40729
	dei	Entity Registrant Name EntityRegistrantName	DATCHAT, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-2502264
	dei	Entity Address Address Line1 EntityAddressAddressLine1	204 Neilson Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	New Brunswick
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	08901
	dei	City Area Code CityAreaCode	(732)
	dei	Local Phone Number LocalPhoneNumber	374-3529
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20938439	shares
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1067593	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1732956	usd
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	8338948	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	11007997	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	107	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	384	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	117162	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	134752	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	9523810	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	12876089	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	98938	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	79694	usd
CY2022Q4	dats	Digital Currencies And Other Digital Assets DigitalCurrenciesAndOtherDigitalAssets	23381	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	105744	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	134526	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	204682	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	237601	usd
CY2023Q2	us-gaap	Assets Assets	9728492	usd
CY2022Q4	us-gaap	Assets Assets	13113690	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	428299	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	404600	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	75168	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	67338	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	105	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	186	usd
CY2022Q4	dats	Due To Related Parties DueToRelatedParties	1315	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	503572	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	473439	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	44038	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	83675	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	44038	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	83675	usd
CY2023Q2	us-gaap	Liabilities Liabilities	547610	usd
CY2022Q4	us-gaap	Liabilities Liabilities	557114	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	180000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	180000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20740419	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20740419	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20597419	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20597419	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	2074	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2060	usd
CY2023Q2	dats	Common Stock To Be Issued CommonStockToBeIssued	1389	shares
CY2022Q4	dats	Common Stock To Be Issued CommonStockToBeIssued	1389	shares
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	53794011	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52283634	usd
CY2023Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	669441	shares
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	397969	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	198328	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-44415562	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39729118	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	9180882	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	12556576	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9728492	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13113690	usd
CY2023Q2	us-gaap	Revenues Revenues	172	usd
CY2022Q2	us-gaap	Revenues Revenues	37947	usd
	us-gaap	Revenues Revenues	326	usd
	us-gaap	Revenues Revenues	38756	usd
CY2023Q2	dats	Compensation And Related Expenses CompensationAndRelatedExpenses	1380038	usd
CY2022Q2	dats	Compensation And Related Expenses CompensationAndRelatedExpenses	1701211	usd
	dats	Compensation And Related Expenses CompensationAndRelatedExpenses	2929730	usd
	dats	Compensation And Related Expenses CompensationAndRelatedExpenses	3375941	usd
CY2023Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	46599	usd
CY2022Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	142402	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	160402	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	580644	usd
CY2023Q2	dats	Professional And Consulting Expenses ProfessionalAndConsultingExpenses	321157	usd
CY2022Q2	dats	Professional And Consulting Expenses ProfessionalAndConsultingExpenses	451515	usd
	dats	Professional And Consulting Expenses ProfessionalAndConsultingExpenses	577077	usd
	dats	Professional And Consulting Expenses ProfessionalAndConsultingExpenses	1465197	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	337458	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	684032	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	241679	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	238405	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	438781	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	480039	usd
CY2022Q2	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	84180	usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	23381	usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	84180	usd
CY2023Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2326931	usd
CY2022Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2617713	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	4813403	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	5986001	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2326759	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2579766	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4813077	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5947245	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	491	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1785	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	5852	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	3418	usd
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	106538	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-66	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-66	usd
CY2023Q2	dats	Realized Gain On Shortterm Investments RealizedGainOnShorttermInvestments	39104	usd
	dats	Realized Gain On Shortterm Investments RealizedGainOnShorttermInvestments	61981	usd
CY2022Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	-3731	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-47672	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-3731	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	39529	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1946	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	126633	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-313	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2287230	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2581712	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4686444	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5947558	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2287230	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2581712	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4686444	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5947558	usd
CY2023Q2	dats	Unrealized Gain On Shortterm Investments UnrealizedGainOnShorttermInvestments	112535	usd
	dats	Unrealized Gain On Shortterm Investments UnrealizedGainOnShorttermInvestments	197570	usd
CY2023Q2	dats	Unrealized Foreign Currency Translation Gain UnrealizedForeignCurrencyTranslationGain	582	usd
	dats	Unrealized Foreign Currency Translation Gain UnrealizedForeignCurrencyTranslationGain	758	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2174113	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2581712	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4488116	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5947558	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.3
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20740419	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19608408	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20689065	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19602944	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	12556576	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	603278	usd
CY2023Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	21900	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	100000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-311174	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	132883	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2399214	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	10704249	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	752155	usd
CY2023Q2	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	33058	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-86795	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	65445	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2287230	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	9180882	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20084014	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	233245	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2913281	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7908356	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-203	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1315	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-397969	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-399284	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-203	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-666121	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	822583	usd
CY2022Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	202275	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3365846	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	17743026	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	772197	usd
CY2022Q2	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	35284	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1090000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2581712	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	17058795	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4686444	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5947558	usd
	us-gaap	Depreciation Depreciation	12941	usd
	us-gaap	Depreciation Depreciation	7766	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	28782	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	23699	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1355433	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1594780	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	118936	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	237559	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	106538	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	23381	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	84180	usd
	us-gaap	Noncash Contribution Expense NoncashContributionExpense	13831	usd
	us-gaap	Other Noncash Income OtherNoncashIncome	36394	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	61981	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-47672	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-3731	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-277	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-35	usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-42000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-53612	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-323604	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	23699	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	27534	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-81	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1539	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-31807	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-25433	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3180118	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3694205	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	3845000	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	964072	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	7649518	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	32185	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25593	usd
	dats	Increase In Cash From Consolidation Of Variable Interest Entities IncreaseInCashFromConsolidationOfVariableInterestEntities	64538	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-11602764	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	758	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1732956	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20199735	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1067593	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8596971	usd
	dats	Intangible Assets Used To Pay Accounts Payable IntangibleAssetsUsedToPayAccountsPayable	112500	usd
	us-gaap	Stock Issued1 StockIssued1	100000	usd
	dats	Issuance Of Common Shares For Intangible Assets IssuanceOfCommonSharesForIntangibleAssets	1090000	usd
CY2023Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	800	usd
CY2023Q1	dats	Percentage Of Share Issued And Outstanding PercentageOfShareIssuedAndOutstanding	0.40	pure
CY2022Q2	dats	Number Of Acquisition Share NumberOfAcquisitionShare	1000000	shares
CY2023Q1	us-gaap	Variable Interest Entity Initial Consolidation Gain Or Loss VariableInterestEntityInitialConsolidationGainOrLoss	106538	usd
CY2023Q2	us-gaap	Cash Cash	40235	usd
CY2023Q1	us-gaap	Cash Cash	64538	usd
CY2023Q1	dats	Due From Datchat DueFromDatchat	42000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Owned Net PropertyPlantAndEquipmentOwnedNet	30808	usd
CY2023Q2	dats	Total Asset TotalAsset	71043	usd
CY2023Q1	dats	Total Asset TotalAsset	106538	usd
CY2023Q2	dats	Due To Parent Company DueToParentCompany	488806	usd
CY2023Q2	us-gaap	Other Liabilities OtherLiabilities	488806	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4686444	usd
CY2023Q2	us-gaap	Cash Including Discontinued Operations CashIncludingDiscontinuedOperations	3180118	usd
CY2023Q2	dats	Accumulated Deficit For The Period AccumulatedDeficitForThePeriod	44415562	usd
CY2023Q2	us-gaap	Capital Capital	9020238	usd
CY2023Q2	us-gaap	Investments And Cash InvestmentsAndCash	1067593	usd
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	8338948	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Use of estimates</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the consolidated financial statements and during the reporting period. Actual results could materially differ from these estimates. Significant estimates include assumptions used in assessing impairment of long-term assets, the valuation of intangible assets, the valuation of digital currencies and other digital assets, the valuation of lease liabilities and related right of use assets, the valuation of short-term investments, the valuation of deferred tax assets, and the fair value of non-cash equity transactions.</p>
	dats	Commonstockequivalents Commonstockequivalents	2025541	shares
CY2023Q1	dats	Granted Aggregate Options Shares GrantedAggregateOptionsShares	215000	shares
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	197570	usd
CY2022Q1	dats	Common Stock Share Issued CommonStockShareIssued	143000	shares
CY2023Q2	dats	Subscription Revenues SubscriptionRevenues	172	usd
CY2022Q2	dats	Subscription Revenues SubscriptionRevenues	1553	usd
	dats	Subscription Revenues SubscriptionRevenues	326	usd
	dats	Subscription Revenues SubscriptionRevenues	2362	usd
CY2022Q2	dats	Nft Revenues NFTRevenues	36394	usd
	dats	Nft Revenues NFTRevenues	36394	usd
CY2023Q2	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	172	usd
CY2022Q2	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	37947	usd
	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	326	usd
	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	38756	usd
CY2023Q2	dats	Related Party Amount RelatedPartyAmount	337458	usd
	dats	Related Party Amount RelatedPartyAmount	684032	usd
	dats	Advertising Costs AdvertisingCosts	160402	usd
	dats	Advertising Costs AdvertisingCosts	580644	usd
	dats	Common Stock Warrants CommonStockWarrants	673841	shares
	dats	Common Stock Warrants CommonStockWarrants	736341	shares
	dats	Common Stock Options CommonStockOptions	1587950	shares
	dats	Common Stock Options CommonStockOptions	1289200	shares
	dats	Largest Amount Of Tax Benefit LargestAmountOfTaxBenefit	0.50	pure
	dats	Assets And Liability Description AssetsAndLiabilityDescription	Foreign currency translationThe reporting currency of the Company is the U.S. dollar. Except for Metabizz SAS, the functional currency of the Company is the U.S. dollar. The functional currency of the Company’s VIE, MetaBizz SAS is the Columbian Peso (“COP”). For MetaBizz SAS, results of operations and cash flows are translated at average exchange rates during the period, assets and liabilities are translated at the unified exchange rate at the end of the period, and equity is translated at historical exchange rates. As a result, amounts relating to assets and liabilities reported on the statements of cash flows may not necessarily agree with the changes in the corresponding balances on the balance sheets. Translation adjustments resulting from the process of translating the local currency financial statements into U.S. dollars are included in determining comprehensive loss. The cumulative translation adjustment and effect of exchange rate changes on cash for the six months ended June 30, 2023 was $758. Transactions denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing on the transaction dates. Assets and liabilities denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing at the balance sheet date with any transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency included in the results of operations as incurred.For MetaBizz SAS, located in located in Columbia, asset and liability accounts on June 30, 2023 were translated at 0.000240 COP to $1.00, which was the exchange rate on the balance sheet date, and results of operations and cash flows are translated at the average exchange rates during the period of 0.00021927 COP to $1.00.
CY2023Q2	us-gaap	Cash Held In Foreign Currency CashHeldInForeignCurrency	758	usd
	dats	Commonstockequivalents Commonstockequivalents	2261791	shares
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	8141378	usd
	dats	Unrealized Gains Loss On Investments UnrealizedGainsLossOnInvestments	197570	usd
CY2023Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	8338948	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	10960325	usd
CY2022	dats	Unrealized Gains Loss On Investments UnrealizedGainsLossOnInvestments	47672	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	11007997	usd
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	2567	usd
CY2021Q4	dats	Expired Term ExpiredTerm	2024-12-31
CY2021Q4	us-gaap	Advance Rent AdvanceRent	7156	usd
CY2023Q2	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.03	pure
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	45477	usd
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	45531	usd
CY2021Q3	dats	Operating Lease Rightof Use Asset And Liabilities OperatingLeaseRightofUseAssetAndLiabilities	198898	usd
CY2021Q3	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P21M
CY2021Q3	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	0.18	pure
CY2023Q2	dats	Common Share Fair Values CommonShareFairValues	100000	usd
	dats	Per Share Based On Sales PerShareBasedOnSales	0.7
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	36022	usd
CY2023Q2	dats	Office Lease OfficeLease	-198898	usd
CY2022Q4	dats	Office Lease OfficeLease	-198898	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	93154	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	64372	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	105744	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	134526	usd
CY2023Q2	dats	Office Leases OfficeLeases	198898	usd
CY2022Q4	dats	Office Leases OfficeLeases	198898	usd
CY2023Q2	dats	Reduction Of Lease Liability ReductionOfLeaseLiability	-79692	usd
CY2022Q4	dats	Reduction Of Lease Liability ReductionOfLeaseLiability	-47885	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	119206	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	151013	usd
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	75168	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	67338	usd
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	44038	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	83675	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	90674	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	46393	usd
CY2023Q2	dats	Operating Leases Future Minimum Payment Due OperatingLeasesFutureMinimumPaymentDue	137067	usd
CY2023Q2	dats	Present Value Discount PresentValueDiscount	-17861	usd
CY2023Q2	dats	Total Operating Lease Liability TotalOperatingLeaseLiability	119206	usd
CY2022Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	4
CY2022Q3	dats	Granted Aggregate Options Shares GrantedAggregateOptionsShares	325000	shares
CY2022Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	4
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	0.25	pure
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	751681	usd
CY2021Q1	dats	Granted Aggregate Options Shares GrantedAggregateOptionsShares	75000	shares
CY2021Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	1.25
CY2022Q2	dats	Aggregate Of Shares AggregateOfShares	1000000	shares
CY2022Q2	dats	Acquisition Share Value AcquisitionShareValue	1090000	usd
CY2022Q2	dats	Share Prices SharePrices	1.09
CY2022Q2	us-gaap	Fiscal Period Duration FiscalPeriodDuration	P5Y
CY2022Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1090000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	109000	usd
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	981000	usd
CY2023Q2	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	0	usd
CY2022Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	1315	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	1315	usd
CY2022Q3	us-gaap	Payments For Software PaymentsForSoftware	185600	usd
CY2023Q2	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	200000000	shares
CY2021Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	2000000	shares
CY2016Q3	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	In August 2016, the Company designated one share of Series A Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”), which has a stated value equal to $1.00 as may be adjusted for any stock dividends, combinations or splits. Each one (1) share of the Series A Preferred Stock shall have voting rights equal to (x) the total issued and outstanding Common Stock eligible to vote at the time of the respective vote divided by (y) forty-nine one hundredths (0.49) minus (z) the total issued and outstanding Common Stock eligible to vote at the time of the respective vote.
CY2023Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	2000000	usd
CY2021Q1	dats	Aggreement Issued Shares AggreementIssuedShares	100000	shares
CY2021Q1	dats	Common Share Fair Values CommonShareFairValues	400000	usd
CY2021Q1	dats	Per Share Based On Sales PerShareBasedOnSales	4
CY2022Q1	dats	Stock Based Consulting StockBasedConsulting	50000	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	154542	usd
	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	0.5329
	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	306250	shares
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	133190	usd
	us-gaap	Professional Fees ProfessionalFees	25525	usd
	dats	Remaining Balance Of Stock Based Consulting RemainingBalanceOfStockBasedConsulting	1410391	usd
CY2022Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1782339	usd
	dats	Stock Issued During Period Shares Issued For Service StockIssuedDuringPeriodSharesIssuedForService	771922	usd
	dats	Weighted Average Period WeightedAveragePeriod	P0Y8M12D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	673841	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.98
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y7M24D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	673841	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.98
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y1M24D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	673841	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice	4.98
	dats	Weighted Average Remaining Contractual Life Years Warrants Exercisable WeightedAverageRemainingContractualLifeYearsWarrantsExercisable	P3Y1M24D
CY2022Q4	dats	Common Stock Share Issued CommonStockShareIssued	0	shares
CY2023Q1	dats	Rounding Rounding		usd
CY2021Q3	dats	Employment Agreement Description EmploymentAgreementDescription	(i) base salary will increase to $450,000 per year, and (ii) Mr. Myman may be entitled to receive an annual bonus in an amount up to $350,000, which annual bonus may be increased by the Compensation Committee of the Board of Directors of the Company (the “Compensation Committee”), in its sole discretion, upon the achievement of additional criteria established by the Compensation Committee from time to time (the “Annual Bonus”). The Employment Agreement provides for a term of one (1) year (the “Initial Term”) from the date of the Effective Date and shall automatically be extended for additional terms of one (1) year each (each a “Renewal Term”) unless either party gives prior written notice of non-renewal to the other party no later than six (6) months prior to the expiration of the Initial Term, or the then current Renewal Term, as the case may be. In addition, pursuant to the Employment Agreement, upon termination of Mr. Myman’s employment for death or Total Disability (as defined in the Employment Agreement), in addition to any accrued but unpaid compensation and vacation pay through the date of his termination and any other benefits accrued to him under any Benefit Plans (as defined in the Employment Agreement) outstanding at such time and the reimbursement of documented, unreimbursed expenses incurred prior to such termination date (collectively, the “Payments”), Mr. Myman shall be entitled to the following severance benefits: (i) 24 months of his then base salary; (ii) if Mr. Myman elects continuation coverage for group health coverage pursuant to COBRA Rights (as defined in the Employment Agreement), then for a period of 24 months following Mr. Myman’s termination he will be obligated to pay only the portion of the full COBRA Rights cost of the coverage equal to an active employee’s share of premiums (if any) for coverage for the respective plan year; and (iii) payment on a pro-rated basis of any Annual Bonus or other payments earned in connection with any bonus plan to which Mr. Myman was a participant as of the date of his termination (together with the Payments, the “Severance”). Furthermore, pursuant to the Employment Agreement, upon Mr. Myman’s termination (i) at his option (A) upon 90 days prior written notice to the Company or (B) for Good Reason (as defined in the Employment Agreement), (ii) termination by the Company without Cause (as defined in the Employment Agreement) or (iii) termination of Mr. Myman’s employment within 40 days of the consummation of a Change in Control Transaction (as defined in the Employment Agreement), Mr. Myman shall receive the Severance; provided, however, Mr. Myman shall be entitled to a pro-rated Annual Bonus of at least $200,000. In addition, any equity grants issued to Mr. Myman shall immediately vest upon termination of Mr. Myman’s employment by him for Good Reason or by the Company at its option upon 90 days prior written notice to Mr. Myman, without Cause.
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1
	us-gaap	Preferred Stock Amount Of Preferred Dividends In Arrears PreferredStockAmountOfPreferredDividendsInArrears	10	usd
CY2023Q2	dats	Preferred Stock Value1 PreferredStockValue1		usd
CY2022Q4	dats	Preferred Stock Value1 PreferredStockValue1		usd
CY2022Q4	dats	Common Stockvalueone CommonStockvalueone		usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue		usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares		shares
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2023Q2	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt		usd
CY2022Q2	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt		usd
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt		usd
CY2022Q2	dats	Realized Gain On Shortterm Investments RealizedGainOnShorttermInvestments		usd
	dats	Realized Gain On Shortterm Investments RealizedGainOnShorttermInvestments		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Noncash Contribution Expense NoncashContributionExpense		usd
	us-gaap	Other Noncash Income OtherNoncashIncome		usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments		usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties		usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		usd
	dats	Increase In Cash From Consolidation Of Variable Interest Entities IncreaseInCashFromConsolidationOfVariableInterestEntities		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	dats	Intangible Assets Used To Pay Accounts Payable IntangibleAssetsUsedToPayAccountsPayable		usd
	dats	Issuance Of Common Shares For Intangible Assets IssuanceOfCommonSharesForIntangibleAssets		usd
CY2023Q2	dats	Due From Datchat DueFromDatchat		usd
CY2023Q1	dats	Due To Parent Company DueToParentCompany		usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities		usd
CY2023Q2	dats	Nft Revenues NFTRevenues		usd
	dats	Nft Revenues NFTRevenues		usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	dats	Weighted Average Remaining Contractual Life Years Granted WeightedAverageRemainingContractualLifeYearsGranted
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001648960

Files In Submission

Name	View Source	Status
0001213900-23-066984-index-headers.html	Edgar Link	pending
0001213900-23-066984-index.html	Edgar Link	pending
0001213900-23-066984.txt	Edgar Link	pending
0001213900-23-066984-xbrl.zip	Edgar Link	pending
dats-20230630.xsd	Edgar Link	pending
dats-20230630_cal.xml	Edgar Link	unprocessable
dats-20230630_def.xml	Edgar Link	unprocessable
dats-20230630_lab.xml	Edgar Link	unprocessable
f10q0623ex31-1_datchat.htm	Edgar Link	pending
f10q0623ex31-2_datchat.htm	Edgar Link	pending
f10q0623ex32-1_datchat.htm	Edgar Link	pending
f10q0623_datchat.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
dats-20230630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q0623_datchat_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DATS
DatChat, Inc. Stock $dats

2023 Q3 Form 10-Q Financial Statement

#000121390023066984 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DATS DatChat, Inc. Stock $dats

2023 Q3 Form 10-Q Financial Statement

#000121390023066984 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DATS
DatChat, Inc. Stock $dats